A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Terazosin D8 | CAS 1006718-20-2 - Request Quote

Picture of Terazosin D8

Terazosin D8

SZ CAT No:SZ-T013D01
CAS No
1006718-20-2
Mol.F.
C19H17D8N5O4
Mol.Wt.
395.5
Inv. Status
Out of Stock, Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Terazosin D8 is chemically (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl-2,2,3,3,5,5,6,6-d8)(tetrahydrofuran-2-yl)methanone. Terazosin D8 is supplied with detailed characterization data compliant with regulatory guideline. Terazosin D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Terazosin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1006718-20-2

Purchase 1006718-20-2

Order 1006718-20-2

Enquire 1006718-20-2

price of 1006718-20-2

1006718-20-2 Supplier

1006718-20-2 Manufacturer

1006718-20-2 Exporter

buy high quality Terazosin D8

Purchase Terazosin D8

Terazosin D8 suppliers

Terazosin D8 manufacturers

Terazosin D8 price

Order Terazosin D8

Enquire Terazosin D8

Terazosin D8 cost

Terazosin D8 Supplier

Terazosin D8 Distributor

Terazosin D8 for Method Validation

Terazosin Reference Standard

Terazosin D8 for ANDA Filing

Terazosin D8 for Forced Degradation Studies

Terazosin D8 Identification Standards

Terazosin D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,